Combined Low Doses of PPARγ and RXR Ligands Trigger an Intrinsic Apoptotic Pathway in Human Breast Cancer Cells

Ligand activation of peroxisome proliferator-activated receptor (PPAR)γ and retinoid X receptor (RXR) induces antitumor effects in cancer. We evaluated the ability of combined treatment with nanomolar levels of the PPARγ ligand rosiglitazone (BRL) and the RXR ligand 9-cis-retinoic acid (9RA) to prom...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Bonofiglio, Daniela, Cione, Erika, Qi, Hongyan, Pingitore, Attilio, Perri, Mariarita, Catalano, Stefania, Vizza, Donatella, Panno, Maria Luisa, Genchi, Giuseppe, Fuqua, Suzanne A.W., Andò, Sebastiano
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Investigative Pathology 2009
Aiheet:
Regular Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2731145/
https://ncbi.nlm.nih.gov/pubmed/19644018
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2353/ajpath.2009.081078
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia